ECHO Webinar – Gavin Oudit (PEARKO Therapeutics): Jun 15 (11 am – 12 pm EST)

June 15, 2021 @ 11:00 am – 12:00 pm

Please join us for an ECHO webinar on Tuesday June 15, 2021 (11 am – 12 pm EST) featuring Dr. Gavin Oudit (Founder & Chief Operating Officer, PEARKO Therapeutics Inc.; Professor, Department of Medicine, University of Alberta; Clinician-Scientist, Mazankowski Alberta Heart Institute; Director, Heart Function Clinic; Canada Research Chair in Heart Failure).


Dr. Oudit’s presentation entitled, “Apelin Analogs as Novel Biologics for Cardiovascular Disease”, will feature an overview of PEARKO Therapeutics, its technologies and the story behind its success. PEARKO Therapeutics is a biopharmaceutical company engaged in the practice of translational medicine: catalyzing and driving the translation of molecular discoveries to patients. PEARKO Therapeutics has established itself in the field of cardiovascular medicine with its highly effective and highly versatile biologic: apelin analog therapy.


Register in advance for this meeting:


After registering, you will receive a confirmation email containing information about joining the webinar.


ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).

© 2021 Faculty of Applied Science & Engineering